Skip to main content

Find Clinical Trials

Home
Conditions
Inflammatory Breast Neoplasms

Clinical trial condition

Inflammatory Breast Neoplasms

Explore clinical trials studying Inflammatory Breast Neoplasms. Study availability and eligibility vary by location and protocol.

74 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Inflammatory Breast Neoplasms trial results

Completed

Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer

NCT01426880

Conditions: Adenocarcinoma, Breast Cancer Female NOS, Breast Diseases, +19 more
Locations: Praxis Dr. Heinrich Fürstenwalde, Brandenburg, Germany

Luisenkrankenhaus Düsseldorf, North Rhine-Westphalia, Germany

NCT Heidelberg Heidelberg, Germany

View Trial Details

Completed

Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial

NCT00475085

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +10 more
Locations: MBCCOP - Gulf Coast Mobile, Alabama, United States

CCOP - Central Illinois Decatur, Illinois, United States

CCOP - Wichita Wichita, Kansas, United States

CCOP - Grand Rapids Grand Rapids, Michigan, United States

View all 16 locations

View Trial Details

Completed

Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer

NCT00105950

Conditions: Breast Diseases, Breast Neoplasms, Inflammatory Breast Neoplasms, +5 more
Locations: GSK Investigational Site Miami, Florida, United States

GSK Investigational Site Chicago, Illinois, United States

GSK Investigational Site Zion, Illinois, United States

GSK Investigational Site Bethesda, Maryland, United States

View all 27 locations

View Trial Details

Completed

Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer

NCT00070252

Conditions: Adult Solid Neoplasm, Breast Diseases, Breast Neoplasms, +10 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Howard University Cancer Center CCOP Washington D.C., District of Columbia, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

NCT00017095

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Institut Jules Bordet Brussels, Belgium

CHU Liege - Domaine Universitaire du Sart Tilman Liège, Belgium

Algemeen Ziekenhuis Sint-Augustinus Wilrijk, Belgium

Centre Paul Papin Angers, France

View all 39 locations

View Trial Details

Completed

Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

NCT00288002

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Universitaetsfrauenklinik Frankfurt Neu-Isenburg, Germany

View Trial Details

Completed

AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

NCT00310089

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States

View Trial Details

Completed

Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer

NCT00004925

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer

NCT00049114

Conditions: Breast Diseases, Breast Neoplasms, Inflammatory Breast Cancer, +9 more
Locations: Albert Einstein College of Medicine The Bronx, New York, United States

View Trial Details

Completed

Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

NCT00072319

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details